Business model and strategy
Taj Life Sciences develops its activities and focuses them on rapidly
evolving therapeutic markets -cancer, serious viral diseases (such as HIV) and
opportunistic infectionsto respond to the needs of specialist physicians,
particularly in the hospital setting.
The Company designs and manufactures innovative products, based on active
pharmaceutical ingredients already recognized on the market with a proven
efficacy and tolerance profile, as well as developing new entities. It more
specifically targets diseases for which the medical needs are insufficiently met
and where the phenomenon of drug resistance leads to particularly serious
consequences.
Our teams have the key competencies required to identify, design, develop and
register drugs in Europe and the USA. Our development choices enable us to
balance the risks in our product portfolio and to accelerate market launch of
our products.
Positioning ourselves on our targeted markets, we have a European sales force
and pursue an active license policy with industrial partners, particularly in
the United States and Asia. This strategy allows us to diversify our direct and
indirect revenues, while capitalizing on our structures and promoting synergies.
*
Business
model and strategy>>
*
Drug Technologies
*
Discovery Research Projects
*
Products in Development
*
Business Development
*
THE NEXT DIMENSION
COMPANY